PetMed Express (NASDAQ: PETS) has been around for a long time, expanding its foothold in the lucrative pet care market at a
Stable demand should help PetMed (PETS) emerge stronger from pandemic
Categories
pharmaceuticals
CureVac (CVAC): Another COVID-19 stock that attracted investors
In recent times, investors have been betting on the biotech companies that are in the race to develop the COVID-19 vaccine. The
Veru Inc. (VERU) Q3 2020 Earnings Call Transcript
Veru Inc. (NASDAQ: VERU) Q3 2020 earnings call dated Aug. 13, 2020 Corporate Participants: Samuel Fisch -- Director, Investor Relations Mitchell Steiner -- Chairman, President, and
Inovio (INO) aims to produce 100 million doses of COVID-19 vaccine in 2021
Shares of INOVIO (NASDAQ: INO) were down over 23% on Tuesday, a day after the company reported second quarter 2020 earnings results
Oncology to COVID-19: Karyopharm (KPTI) CEO on what’s ahead
The oncology research space has become rather crowded these days, with numerous clinical-level companies cropping up with novel technologies. While these offer
Cardinal Health Inc. (CAH) Q4 2020 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q4 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Kevin Moran -- Vice President-Investor Relations Michael C. Kaufmann -- Chief
Zoetis Inc. (ZTS) Q2 2020 Earnings Call Transcript
Zoetis Inc. (NYSE: ZTS) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Steve Frank -- Vice President of Investor Relations KristIn Peck -- Chief
Karyopharm Therapeutics Inc. (KPTI) Q2 2020 Earnings Call Transcript
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Ian Karp -- Vice President, Investor and Public Relations
Mylan N.V. (MYL) Q2 2020 Earnings Call Transcript
Mylan N.V. (NASDAQ: MYL) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Melissa Trombetta -- Head of Global Investor Relations Heather Bresch -- Chief
Highlights of Bristol-Myers Squibb Company (NYSE: BMY) Q2 2020 Earnings
https://www.youtube.com/watch?v=dYv_jstT8BY&t=18s Pharmaceutical firm Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2020 financial results on Thursday morning. The results were better than analysts’
Teva Pharmaceuticals (TEVA) Q2 2020 earnings: Reaffirms FY20 outlook
Teva Pharmaceuticals (NYSE: TEVA) beat Q2 earnings estimates, but fell short of Street's revenue targets. The drug manufacturer reported adjusted EPS of
Amarin (AMRN) maintains revenue growth despite COVID-19 headwinds
Amarin Corporation plc (NASDAQ:AMRN) reported second quarter 2020 earnings results today. The company reported a 34% growth in total revenue to $135.3
McKesson Corp. (MCK) Q1 2021 Earnings Call Transcript
McKesson Corp. (NYSE: MCK) Q1 2021 earnings call dated Aug. 03, 2020 Corporate Participants: Holly Weiss -- Senior Vice President of Investor Relations Brian
Strong performance of oncology products bode well for AbbVie (ABBV) going forward
AbbVie Inc. (NYSE: ABBV) reported better-than-expected results for the second quarter of 2020 on Friday. The company reported a 26% increase in
Merck & Co., Inc. (MRK) Q2 2020 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q2 2020 earnings call dated July 31, 2020 https://youtu.be/kKm2dyqbeW0 Corporate Participants: Peter Dannenbaum -- Vice President of Investor
Eli Lilly & Co. (LLY) Q2 2020 Earnings Call Transcript
Eli Lilly & Co. (NYSE: LLY) Q2 2020 earnings call dated July 30, 2020 https://www.youtube.com/watch?v=d4-cSFo067A Presentation: Operator Ladies and gentlemen, thank you
Baxter International Inc. (BAX) Q2 2020 Earnings Call Transcript
Baxter International Inc. (NYSE: BAX) Q2 2020 earnings call dated Jul. 30, 2020 Corporate Participants: Clare Trachtman -- Vice President, Investor Relations Jose (Joe)
AbbVie (ABBV) Q2 2020 results beat estimates; updates FY20 outlook
AbbVie (NYSE: ABBV), which completed the acquisition of Allergan on May 8, 2020, reported second quarter 2020 earnings results today. The company's
Merck (MRK) sales decline 8% in Q2 2020; raises FY20 outlook
Merck (NYSE: MRK) reported an 8% drop in second quarter sales, reflecting the negative impact of COVID-19. However, sales of $10.9 billion
AstraZeneca PLC (AZN) Q2 2020 Earnings Call Transcript
AstraZeneca PLC (NYSE: AZN) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Pascal Soriot -- Executive Director and Chief Executive Officer Dave
LLY Earnings: All you need to know about Eli Lilly Q2 2020 earnings results
Eli Lilly and Company (NYSE: LLY) reported second quarter 2020 earnings results today. Revenues declined 2% year-over-year to $5.4 billion. Reported net